Your Location:
Home >
Browse articles >
Jisheng Shenqi Pills Treat Chronic Kidney Disease in Rats via cAMP/AQP2/NLRP3 Pathway
Jisheng Shenqi Pills Treat Chronic Kidney Disease in Rats via cAMP/AQP2/NLRP3 Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 16, Pages: 52-59(2024)
DOI: 10.13422/j.cnki.syfjx.20240441
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 2 ) Tabs( 7 )
References
Publication Info
Metrics
329
Views
301
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanisms of Dahuang Gancaotang in Improving Ferroptosis in Chronic Kidney Disease through SIRT3-mediated Deacetylation of p53
Mechanisms of Bushen Tongluo Jiangzhuo Prescription in Improving Renal Fibrosis in Rats with Chronic Kidney Disease Based on PI3K/Akt/mTOR Signaling Pathway
Ameliorating Effect of Yifei Tongluo Prescription on Bleomycin-induced Pulmonary Fibrosis in Rats via Regulating NLRP3/Caspase-1/GSDMD Signaling Pathway and Epithelial-mesenchymal Transition
Nuanxinkang Ameliorates Doxorubicin-induced Cardiomyopathy in Mice by Regulating NLRP3/DAMPs Signaling Pathway and Inhibiting Neutrophil Extracellular Trap Formation
Syndrome Differentiation and Treatment of Asymptomatic Renal Hematuria Population Based on Association of Age-Constitution-Syndrome
Related Author
CUI Mengdi
AN Yi
WANG Rui
XIONG Zhili
BAO Xincui
ZHAO Baosheng
QIN Lingling
WANG Haiyan
Related Institution
Geriatric Hospital of Wuhan University of Science and Technology
Hubei University of Chinese Medicine
Hubei Provincial Hospital of Traditional Chinese Medicine(TCM)
Affiliated Hospital of Hubei University of Chinese Medicine
Hubei Research Institute of TCM


